12 results
·
30ms
·
Sources: EU EUDAMED, US FDA
ACCULASER PRO LOW LEVEL LASER THERAPY DEVICE
FDA 510(k)
FDA Class 2
·Physical Medicine
eSensor® XT-8
FDA UDI
GENMARK DIAGNOSTICS, INC.·00857167005146·eSensor® Cystic Fibrosis Genotyping Test Cartri...
Midway Select
FDA UDI
MIDWAY DENTAL SUPPLY, LLC·00843717108764·Midway Select Expro 23/CP11 Double End Color Co...
EECP THERAPY SYSTEM, MODEL TS3
FDA Adverse Event
Injury
·VASOMEDICAL, INC.·Product code DRN·December 30, 2002
LUER ACCESS UNIVERSAL VIAL ADAPTER
FDA 510(k)
FDA Class 2
·General Hospital
COPELAND MB RESURFACING HUMERAL HEADS
FDA 510(k)
FDA Class 2
·Orthopedic
CONTOUR
FDA Adverse Event
Injury
·BAYER HEALTHCARE, LLC·Product code NBW·April 30, 2010
BAXANO IO-FLEX MICROBLADE SHAVER
FDA Adverse Event
Other
·BAXANO, INC.·Product code HAE·March 21, 2013
SWAN-GANZ, VIP
FDA Adverse Event
Malfunction
·EDWARDS LIFESCIENCES·Product code DYG·March 7, 2011
PUMP MMT-512LNAS PRDGM INS SK EN US LN
FDA Adverse Event
Injury
·MEDTRONIC MINIMED·Product code LZG·March 27, 2008
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014